Liver Disease

NAFLD Linked to Increased Risk of Metabolic Syndrome in Patients Without MAFLD

September 27th 2022, 7:20pm


Among individuals without metabolic-associated fatty liver disease (MAFLD), those with nonalcoholic fatty liver disease (NAFLD) had a higher risk of developing metabolic syndrome.

Study Identifies Gut Microbiota Linked to HE Pathophysiology

September 24th 2022, 6:41pm


Urease-positive Streptococcus salivarius was the most significantly abundant gut microbiota in patients with HE.

Dr Pichamol Jirapinyo Discusses Endoscopic Gastric Plication in Patients With NAFLD

September 22nd 2022, 6:51pm


Pichamol Jirapinyo, MD, MPH, director of bariatric endoscopy fellowship at Brigham and Women's Hospital, explains the implications of her study on the effects of endoscopic gastric plication on liver fibrosis in patients with nonalcoholic steatohepatitis (NASH).

Optimizing Emergency Care Processes Improves Outcomes for Hospitalized Patients With HE

September 16th 2022, 8:30pm


Patients with hepatic encephalopathy (HE) often do not seek care until they are in critical condition, making an optimized emergency care process critical to reduce adverse prognosis and improve clinical symptoms.

Review Outlines Nutrition Assessment, Management in Patients With Cirrhosis

September 14th 2022, 7:14pm


A comprehensive review assessed the ways that proper nutrition could help reduce the adverse effects of hepatic encephalopathy in patients with hepatic encephalopathy.

Rifaximin Plus Lactulose Linked to Greater Effectiveness, Decreased Mortality in HE

September 9th 2022, 4:00pm


Compared with the use of lactulose alone, rifaximin plus lactulose can provide additional benefits in terms of increased effectiveness rate and decreased mortality in patients with hepatic encephalopathy (HE).

Evidence-Based Management Options for Hepatic Encephalopathy Explored in New Review

September 3rd 2022, 8:00pm


A review of 6 studies on treatment options for hepatic encephalopathy found that many require further research before they can be recommended.

Liver Disease Disparities Rarely Studied in Europe, Review Finds

September 2nd 2022, 3:24pm


A new analysis found only 1 in 10 studies of inequities in liver cancer had a European focus or origin.

Individualized Antimicrobial Treatment, Prophylactic Regimens May Help With GVHD After Liver Transplant

June 3rd 2022, 1:54pm


A recent study aimed to provide insight and guidance for managing graft-versus-host disease in patients after liver transplantation.

Study Finds Link Between Psoriasis, NAFLD Among US Adult Outpatients

May 31st 2022, 5:20pm


US adult outpatients with psoriasis have a greater risk of developing nonalcoholic fatty liver disease compared with those without the skin condition.